» Articles » PMID: 38015964

Short Report: Plasma Based Biomarkers Detect Radiation Induced Brain Injury in Cancer Patients Treated for Brain Metastasis: A Pilot Study

Abstract

Background: Radiotherapy has an important role in the treatment of brain metastases but carries risk of short and/or long-term toxicity, termed radiation-induced brain injury (RBI). As the diagnosis of RBI is crucial for correct patient management, there is an unmet need for reliable biomarkers for RBI. The aim of this proof-of concept study is to determine the utility of brain-derived circulating free DNA (BncfDNA), identified by specific methylation patterns for neurons, astrocytes, and oligodendrocytes, as biomarkers brain injury induced by radiotherapy.

Methods: Twenty-four patients with brain metastases were monitored clinically and radiologically before, during and after brain radiotherapy, and blood for BncfDNA analysis (98 samples) was concurrently collected. Sixteen patients were treated with whole brain radiotherapy and eight patients with stereotactic radiosurgery.

Results: During follow-up nine RBI events were detected, and all correlated with significant increase in BncfDNA levels compared to baseline. Additionally, resolution of RBI correlated with a decrease in BncfDNA. Changes in BncfDNA were independent of tumor response.

Conclusions: Elevated BncfDNA levels reflects brain cell injury incurred by radiotherapy. further research is needed to establish BncfDNA as a novel plasma-based biomarker for brain injury induced by radiotherapy.

Citing Articles

The current research status of the mechanisms and treatment of radioactive brain injury.

Wang Y, Bao X, Zhang Y, Wu Q Am J Cancer Res. 2025; 14(12):5598-5613.

PMID: 39803653 PMC: 11711531. DOI: 10.62347/BEAU4974.


Ferroptosis in radiation-induced brain injury: roles and clinical implications.

Li L, Liu X, Han C, Tian L, Wang Y, Han B Biomed Eng Online. 2024; 23(1):93.

PMID: 39261942 PMC: 11389269. DOI: 10.1186/s12938-024-01288-y.


EDA2R reflects the acute brain response to cranial irradiation in liquid biopsies.

Romero A, Seitz T, Zisiadis G, Jeffery H, Osman A Neuro Oncol. 2024; 26(9):1617-1627.

PMID: 38683135 PMC: 11376461. DOI: 10.1093/neuonc/noae077.

References
1.
Zach L, Guez D, Last D, Daniels D, Grober Y, Nissim O . Delayed contrast extravasation MRI: a new paradigm in neuro-oncology. Neuro Oncol. 2014; 17(3):457-65. PMC: 4483101. DOI: 10.1093/neuonc/nou230. View

2.
Zemmour H, Planer D, Magenheim J, Moss J, Neiman D, Gilon D . Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA. Nat Commun. 2018; 9(1):1443. PMC: 5915384. DOI: 10.1038/s41467-018-03961-y. View

3.
Rahman R, Alexander B, Wen P . Neurologic Complications of Cranial Radiation Therapy and Strategies to Prevent or Reduce Radiation Toxicity. Curr Neurol Neurosci Rep. 2020; 20(8):34. DOI: 10.1007/s11910-020-01051-5. View

4.
Smart D . Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction. Semin Radiat Oncol. 2017; 27(4):332-339. PMC: 5657507. DOI: 10.1016/j.semradonc.2017.04.006. View

5.
Sun K, Jiang P, Chan K, Wong J, Cheng Y, Liang R . Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc Natl Acad Sci U S A. 2015; 112(40):E5503-12. PMC: 4603482. DOI: 10.1073/pnas.1508736112. View